Management of Appendiceal Inflammatory Mass: Nonoperative Treatment, Malignancy Risk, and Surveillance
The American Surgeon™ · 2026-09 · 92 (9) · 2378-2386
DOI: 10.1177/00031348261441674 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 09.04.2026. Verfasst von İlyas Kudaş und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, University of Health Sciences, Cam Sakura Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Appendectomy, Appendiceal Neoplasms, Appendicitis. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
The management of an appendiceal inflammatory mass (historically termed “plastron”) is controversial due to debates over optimal treatment strategies and malignancy risk. This 15-year retrospective study compares medical vs surgical outcomes, provides granular malignancy data, and aims to establish a risk-stratified surveillance protocol. Material and Methods This STROBE-compliant retrospective study analyzed 79 consecutive patients (2009-2024) with radiologically confirmed appendiceal inflammatory masses at University of Health Sciences, Ümraniye Training and Research Hospital. We performed propensity score-adjusted comparisons between medical (antibiotics ± percutaneous drainage, n = 32) and surgical (n = 47) groups. Outcomes focused on success rates, complications, hospital stay, malignancy (histopathology), and colonoscopic findings.
Results
Medical management was initially successful (68.7%, 22/32), resulting in significantly shorter hospitalization (mean difference 2.8 days, 95% CI: 0.2—5.4, 4.1 ± 2.7 vs 6.9 ± 4.8 days, P = 0.03) and fewer complications (OR 0.35, 95% CI: 0.1—0.9, 9.3% vs 23.4%, P = 0.04) vs surgery. Interval appendectomy was required in 31.2% (10/32) of medical patients. Malignancies were identified in 15.1% overall (95% CI: 7.9%—24.9%), including 6.2% diagnosed only at interval appendectomy. Colonoscopy was performed in 31.6% (25/79) and detected significant neoplasia in 20.0% (5/25; 95% CI: 8.9%–39.1%), predominantly among clinically high-risk patients.
Conclusion
Conservative management is effective, but the substantial malignancy risk (15.1%) and high colonoscopy yield (19%) in this high-risk tertiary cohort necessitate vigilant surveillance. Consistent with updated screening guidance, we recommend colonoscopic evaluation for patients aged ≥45 and/or those with elevated tumor markers or suspicious imaging, and a lower threshold for interval appendectomy in high-risk phenotypes, supporting a risk-stratified approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, University of Health Sciences, Cam Sakura Training and Research Hospital, Istanbul, Turkey.
- Department of General Surgery, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.
- Department of General Surgery, University of Health Sciences, Istanbul Kanuni Training and Research Hospital, Istanbul, Turkey.
ORCID-Profile: İlyas Kudaş, Olgun Erdem, Fatih Başak
Zitieren
APA
Kudaş, İ., Erdem, O., Başak, F., Aliş, Z. Ş., Tosun, H., Calışkan, Y. K., Acar, A., Canbak, T., Tolan, H. K., & Tekeşin, K. (2026). Management of Appendiceal Inflammatory Mass: Nonoperative Treatment, Malignancy Risk, and Surveillance. The American Surgeon™, 92(9), 2378-2386. https://doi.org/10.1177/00031348261441674
Vancouver
Kudaş İ, Erdem O, Başak F, Aliş ZŞ, Tosun H, Calışkan YK, et al. Management of Appendiceal Inflammatory Mass: Nonoperative Treatment, Malignancy Risk, and Surveillance. The American Surgeon™. 2026;92(9):2378-2386. doi:10.1177/00031348261441674
BibTeX
@article{Kuda2026,
author = {Kudaş, İlyas and Erdem, Olgun and Başak, Fatih and Aliş, Zeynep Şevval and Tosun, Hüsna and Calışkan, Yahya Kemal and Acar, Aylin and Canbak, Tolga and Tolan, Huseyin Kerem and Tekeşin, Kemal},
title = {Management of Appendiceal Inflammatory Mass: Nonoperative Treatment, Malignancy Risk, and Surveillance},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {9},
pages = {2378--2386},
doi = {10.1177/00031348261441674}
}
EUVIMED